Abstract
An immunosuppressive cyclic polypeptide, cyclosporin A (CyA), isolated originally from two species of fungi, prolongs organ allograft survival in several species. However, virtually nothing is known about the pharmacokinetics of this substance and its mode of action in man. We have quantified the impact of CyA on T-dependent and T-independent immunoglobulin (Ig) synthesis of human blood leukocytes in vitro, and on the proliferating capacity of the interacting lymphoid cell populations--T cells, B cells, T mu and T gamma cells. CyA inhibited all responses at approximately equal concentrations. The blast cells rather than resting lymphocytes and/or Ig-synthesizing plasma cells were incapacitated by the drug. As the phagocytosis of accessory macrophages was inhibited only at a 100--1,000-fold higher drug concentration, we conclude that CyA has a relatively specific direct effect on human T and B blast cells in vitro.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.